NEW YORK--(BUSINESS WIRE)--ImClone Systems Incorporated (NASDAQ: IMCL), a global leader in the development and commercialization of novel cancer therapeutics, today announced that the Company is scheduled to present at the Stanford Group Company 13th Annual Healthcare Conference in Washington, D.C. on Thursday, January 17, 2008 at 8:15 a.m. EST. A corporate overview will be provided, including additional information on the Company’s product portfolio.
